Renal News: Breaking Renal News, Comments and Articles. - Page: 4

Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study

In adults with chronic kidney disease (CKD), cigarette smoking is associated with an increased risk for CKD progression and transplant failure. Now, a first-of-its-kind study by researchers at Dayton Children’s Hospital and Johns Hopkins University has found a possible similar effect in children with kidney disease who are exposed to secondhand smoke. Dayton, OH (PRWEB) May 21, 2013 In adults w...

Veloxis Pharmaceuticals A/S: European Medicines Agency (EMA) Accepts Veloxis' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients

Company Announcement no. 13/2013 To: NASDAQ OMX Copenhagen A/S Hoersholm, Denmark, May 21, 2013 European Medicines Agency (EMA) Accepts Veloxis' Marketing Authorization Application (MAA) for LCP-Ta...

NxStage Announces New Agreements with DaVita

LAWRENCE, Mass., May 21, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it has entered into new agreements covering its supply of home, critical care and in-center products to DaVita, the kidney care division of DaVita Healthcare Partners Inc. (Logo: http://photos.prnewswire.com/prnh/20110503/MM9479...

Mediterranean Diet Good for Chronic Kidney Disease

Stronger adherence to a Mediterranean-style diet significantly reduces mortality in patients with chronic kidney disease. Medscape Medical News

EMA accepts MAA for LCP-Tacro

Veloxis Pharmaceuticals A/S (CSE:VELO) said EMA accepted for review an MAA for LCP-Tacro tacrolimus to prevent organ rejection in kidney transplant patients. The company said it expects a decision on the application next year. Veloxis also plans to s...

BiologicTx® Unveils Proprietary Transplant Therapeutic Data Management System At The American Transplant Congress

TOTOWA, N.J., May 20, 2013 /PRNewswire/ -- BiologicTx® [www.biologictx.com], the first solely focused infusion and pharmacy provider of biologic and oral transplant therapy management, today announced the unveiling of their new proprietary transplant therapeutic data management and analytics program, BiologicTx Sequence™.  BiologicTx Sequence is a proprietary data management system...

European Medicines Agency (EMA) Accepts Veloxis' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients

HORSHOLM, Denmark, May 21, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO)  today announced that the European Medicines Agency (EMA) accepted for review the company's Marketing Authorization Application (MAA) to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union. Veloxis expects the decision from the European Union in 2014....

U.S. Renal Care pays $7.3 million to settle billing fraud case brought by nurse-whistleblower

BALTIMORE, May 21, 2013 /PRNewswire/ -- U.S. Renal Care has agreed to pay $7.3 million to the federal government to settle a whistleblower lawsuit brought by a nurse that alleged a company U.S. Renal Care acquired, Dialysis Corporation of America (DCA), overcharged Medicare for years for an anemia drug used to treat dialysis patients. The "qui tam" (whistleblower) lawsuit alleged that DCA wa...

Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer

Regulatory News : Transgene SA (Paris:TNG) (Euronext Paris: TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, today announced completion of enrollment in the 120-patient TRAVERSE study. This study is a global randomized phase 2b clinical tri...

Advertencia sobre fármaco no modifica uso en centros médicos con fines de lucro

Por Andrew M. Seaman NUEVA YORK (Reuters Health) - A pesar de una fuerteadvertencia de las autoridades regulatorias de Estados Unidos enel 2007, los centros de diálisis con fines de lucro seguíanutilizando más que los centros sin fines de lucro un...

St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the start of its landmark EnligHTNment clinical study. This is the largest randomized, prospective trial to determine whether renal denervation and medication offers additional health benefits beyond lowering blood pressure in patients with uncontrolled hypertension. The En...

Amgen, Inc. Management Presents at UBS Global Healthcare Conference (Transcript)

Amgen Inc. (AMGN) UBS Global Healthcare Conference Call May 21, 2013 10:00 a.m. ET Executives Joseph P. Miletich - Senior Vice President of Research and Development Analysts Matthew Roden - UBS Presentation Marc Goodman - UBS Good morning, everyone. My name is Matt Roden. I am a biotech analyst here at UBS. And I'd like to thank everyone for coming to the new UBS Global Life Scien...

AbbVie begins atrasentan Phase 3 diabetic nephropathy study

AbbVie has begun Phase 3 study of atrasentan on renal outcomes including the onset of end-stage renal disease (ESRD) transplant or death due to renal failure progression in patients with diabetic nephropathy.

Free Vaginal Mesh Webinar Offered: Registration Now Open

CONCORD, Calif., May 21, 2013 /PRNewswire-iReach/ -- The Life Care Solutions Group is hosting a free vaginal mesh webinar that will provide those with questions about related health complications the opportunity to have them answered by a leading medical expert in the field. Registration is now open for those interested in attending the online event, which has been designed especially for women wh...

Baxter Receives Marketing Authorization for HyQvia in European Union

Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced that the European Commission has granted Baxter marketing authorization in all European Union (EU) Member States for the use of HyQvia (solution for subcutaneous use) as replacement therapy for adult patients with primary and secondary immunodeficiencies....

Veran Medical Introduces vSupport™ Face-to-Face Virtual Support for Electromagnetic Navigation Customers

PHILADELPHIA, May 21, 2013 /PRNewswire/ -- Veran announced today at the American Thoracic Society International Conference that they are partnering with SpotOn Surgical to launch vSupport™ face-to-face virtual support for their existing and growing customer base. The new vSupport product provides virtual customer support during navigation procedures for the lung, liver and kidneys. An experi...

Natural GMOs Part 165. Novel double-stranded RNAs get served up in many conventional crops -- such as rice.

Some people have raised worries about whether novel double-stranded RNA molecules present in plant foods might be harmful to people. Naturally occurring plants often produce novel double-stranded RNA molecules, so we have long been exposed to this risk.One example has been characterised in detail by Japanese scientists. It is low protein variety of rice called  LGC-1 that is used as a diet t...

Zapping Renal Nerves Durably Drives Down BP (CME/CE)

SAN FRANCISCO (MedPage Today) -- The dramatic blood pressure reduction with renal denervation appears sustained in longer-term results from early phase Symplicity and EnligHTN trials.

ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials

ISTANBUL, May 21, 2013 /PRNewswire/ -- The congress of the ERA-EDTA (European Renal Association -  European Dialysis and Transplant Association) is the biggest congress in Europe on nephrology and renal replacement therapy. Nearly 10,000 participants are in Istanbul to share their knowledge and discuss the latest research findings. New pioneering studies have been presented: / (1) Gupt...

Medtronic's Multi-Electrode, Simultaneously Firing Renal Denervation Catheter Shows Reduced Procedure Times While Demonstrating Significant Blood Pressure Reduction

Initial Results from Feasibility Study of the Symplicity Spyral(TM) Catheter Show Safety and Efficacy While More than Halving Mean Procedure Time MINNEAPOLIS and PARIS - MAY 21, 2013 - Medtronic, Inc. (NYSE: MDT) announced today preliminary results from the feasibility study of its Symplicity SpyralTM multi-electrode, 6 Fr renal denervation catheter, which showed safe, significant blood pressur...

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

First Look at Data from Global SYMPLICITY Registry Shows Renal Denervation with the Symplicity(TM) System Meets Performance Expectations in Real-World Setting MINNEAPOLIS and PARIS - MAY 21, 2013 - Medtronic, Inc. (NYSE: MDT), announced today the first results from the Global SYMPLICITY Registry, which reaffirmed the safety of the renal denervation procedure with the Symplicity(TM) renal dener...

AUA To Deliver Testimony On Urotrauma Before House VA Subcommittee On Health

LINTHICUM, Md., May 21, 2013 /PRNewswire-USNewswire/ -- On Tuesday, May 21, the American Urological Association (AUA), a leading advocate for the specialty of urology, will deliver oral and written testimony to the House of Representatives' Veterans Affairs' Subcommittee on Health in support of H.R. 984, a bi-partisan bill that specifically addresses urotrauma, a growing concern among active milit...

Melissa Productions Psychic CEO Raises Awareness for Type 1 Diabetes on Kiss 95.1

Melissa Productions psychic CEO raises awareness for type 1 diabetes on Kiss 95.1 by agreeing to provide the morning show host’s, Maney of ‘Drex and Maney’, wife a psychic consultation with proceeds donated to her daughter's JDRF Walk Team. Matthews, NC (PRWEB) May 21, 2013 Melissa Productions psychic CEO to give Kiss 95.1 morning show host’s wife a psychic consultation with an agreem...

US Drug Watchdog Now Urges Victims Of A Transvaginal Mesh Failure With Severe Complications To Call Them For The Names Of National Caliber Women Lawyers-Get Compensated

The US Drug Watchdog does not believe a woman victim of a transvaginal mesh failure would want to share a gender specific horror story with a male attorney, so they are offering the contacts for national caliber women lawyers, who all are well versed on transvaginal mesh failures, and severe medical complications associated with these failures. For more information women, who are victims of a tran...

Rockwell Medical Run-Up Trade Follows Financing

WIXOM, MI (TheStreet) -- Consider a run-up trade in a biotech stock after it raises money. A recent example: Last January, Trius Therapeutics sold 6.3 million shares at a 9% discount to its market price at the time. Over the next two months -- and ahead of results from a clinical trial of its lead antibiotic -- Trius shares ran up more than 50%. I'm giving this strategy another go with Rockwell...